Friday, June 19, 2026

AI Wellness Revolution: Insights from SK Intellix’s NAMUHX Meetup and Future Hackathon Plans

SK Intellix hosted the 1st NAMUHX Meetup to expand its AI wellness ecosystem, connecting developers and discussing future innovations.

Russia Contacts South Korea Following North Korean Troop Withdrawal As Normalization Of Relations Nears Amid Speculation Of Post-War Shifts

Russia's informal talks with South Korea on North Korean issues reflect diplomatic sensitivity amid strained relations with Pyongyang.

Will North Korea’s New 5-Year Plan Feed the Nation? Kim Jong-un’s Upcoming Party Meeting

North Korea plans a December plenary meeting to assess its five-year plan, with a significant congress expected next year to shape foreign policy.

Tag: SillaJen

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Revolutionary Cancer Treatment SJ-650: What Makes It a Game Changer in Oncology?

SillaJen's SJ-650 cancer treatment platform gains recognition with publication in Molecular Therapy, showcasing its innovative approach and efficacy.

Top News

- Our Sponsors Ad -

Follow us